#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11616	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2063	551.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1671	1671	T	661	T,C	328,301	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11616	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2063	551.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	621	C	592	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20954	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3735	555.2	0	.	n	.	0	T695C	SNP	695	695	T	1112	1112	C	650	C,T	630,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20954	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3735	555.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1754	1754	A	703	A,G	682,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20954	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3735	555.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2388	2388	C	669	C,A	634,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20954	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3735	555.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2462	2462	A	630	A	614	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20954	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3735	555.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3014	3014	C	653	C	634	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1300	folP	855	855	100.0	folP.l15.c4.ctg.1	1613	79.6	1	SNP	p	R229S	1	.	.	685	687	AGC	930	932	AGC	140;140;137	A,C;G;C	133,1;134;131	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3622	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3320	107.8	1	SNP	p	S91F	1	.	.	271	273	TTC	512	514	TTC	129;130;130	T;T,C;C	123;124,1;125	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3622	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3320	107.8	1	SNP	p	D95G	1	.	.	283	285	GGC	524	526	GGC	126;123;122	G;G,A;C	119;117,1;115	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3622	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3320	107.8	1	SNP	p	G95N	0	.	.	283	285	GGC	524	526	GGC	126;123;122	G;G,A;C	119;117,1;115	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1244	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1351	91.0	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	166;166;167	G;G;C	159;159;159	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	592	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	979	59.4	0	.	n	.	0	A197.	DEL	197	197	A	543	543	A	134	A	129	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2815	127.8	1	SNP	p	D86N	0	.	.	256	258	GAC	500	502	GAC	133;131;130	G;A;C	132;131;130	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2815	127.8	1	SNP	p	R87I	0	.	.	259	261	CGT	503	505	CGT	128;129;133	C,A;G;T	125,2;127;130	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2815	127.8	1	SNP	p	R87W	0	.	.	259	261	CGT	503	505	CGT	128;129;133	C,A;G;T	125,2;127;130	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2815	127.8	1	SNP	p	S87R	1	.	.	259	261	CGT	503	505	CGT	128;129;133	C,A;G;T	125,2;127;130	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3656	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2815	127.8	1	SNP	p	S88P	0	.	.	262	264	TCC	506	508	TCC	133;134;136	T;C;C	130;132;135	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2904	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2677	107.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1564	1566	GGC	153;153;150	G;G;C	151;151;147	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1422	1424	GCA	145;147;149	G,A;C;A,C	141,1;141;145,2	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1425	1427	ATC	150;151;150	A;T,C;C,G	147;146,1;140,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1437	1439	GTG	148;146;147	G,A;T,C;G,C	143,1;140,1;143,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1437	1439	GTG	148;146;147	G,A;T,C;G,C	143,1;140,1;143,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1941	1943	ACC	139;139;141	A;C;C	124;133;134	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1995	1997	GCG	124;123;124	G;C,G;G	118;110,2;117	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1995	1997	GCG	124;123;124	G;C,G;G	118;110,2;117	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2118	2120	AGC	121;121;121	A,G;G;C,T	111,2;114;114,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2127	2129	GGC	107;105;106	G;G;C	104;101;101	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2828	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2582	107.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2145	2147	CCG	84;84;83	C,G;C;G	72,1;74;71	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4290	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3030	139.9	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1454	1456	ACG	160;159;159	A,G;C;G	151,2;150;150	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4290	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3030	139.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1592	1594	CCG	138;135;135	C;C;G	130;131;133	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1574	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1807	85.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	568	568	C	110	C	108	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	101	103	TTA	43;43;43	T;T;A	43;43;43	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	146	148	CAT	38;36;35	C;A;T,C	38;36;34,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	149	151	AGT	35;35;36	A;G;T	35;34;35	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	158	160	TAC	36;36;36	T;A;C	36;35;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	R307A	NONSYN	919	921	AGA	248	250	GCA	16;17;17	G;C;A	16;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	260	262	GCA	17;19;19	G;C;A	17;19;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	263	265	GAC	19;19;19	G;A;C	19;19;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	269	271	ATC	19;21;21	A;T;C	19;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	275	277	TCG	20;20;20	T;C;G	20;20;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	281	283	GCC	19;19;18	G;C;C	19;19;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	284	286	AGC	18;18;18	A;G;C	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	287	289	GCC	18;19;19	G;C;C	18;19;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	282	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	387	25.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	293	295	GTT	18;18;18	G;T;T	18;18;18	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	414	416	GAA	195;197;197	G,A;A;A	188,1;194;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	702	704	GAT	180;184;184	G,A;A;T	176,2;180;182	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	825	827	TCA	159;161;163	T;C;A	156;158;161	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	954	956	GTC	160;160;159	G;T;C	155;154;158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	966	968	TCT	158;159;160	T;C,T;T	154;156,2;158	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1284	1286	GCA	192;191;194	G;C,A;A	186;185,2;190	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	AAG	191;190;192	A;A;G	182;181;179	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	1	SNP	p	A121D	1	.	.	361	363	GAC	663	665	GAC	193;193;193	G,A;A;C	185,2;182;183	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2324	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1577	145.8	1	SNP	p	D121N	0	.	.	361	363	GAC	663	665	GAC	193;193;193	G,A;A;C	185,2;182;183	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8220	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4760	170.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1062	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1183	88.9	1	SNP	p	V57M	1	.	.	169	171	ATG	623	625	ATG	196;196;196	A;T;G	193;191;193	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	376	94.68	tetM.l15.c30.ctg.1	376	1.9	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	28	30	CTA	2;2;2	C;T;A	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	376	94.68	tetM.l15.c30.ctg.1	376	1.9	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	70	72	AAT	3;3;3	A;A;T	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	376	94.68	tetM.l15.c30.ctg.1	376	1.9	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	139	141	TCA	3;3;3	T;C;A	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	376	94.68	tetM.l15.c30.ctg.1	376	1.9	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	163	165	ATG	2;2;2	A;T;G	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	205	98.54	tetM.l15.c30.ctg.2	266	1.9	0	.	p	.	0	C585trunc	TRUNC	1753	1753	T	38	38	T	2	T	0	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	205	98.54	tetM.l15.c30.ctg.2	266	1.9	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	47	49	GAA	2;2;2	G;A;A	1;1;0	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	24	tetM	1920	205	98.54	tetM.l15.c30.ctg.2	266	1.9	0	.	p	.	0	D592N	NONSYN	1774	1776	GAT	59	61	AAT	2;2;2	A;A;T	0;1;1	.	Tetracycline resistance
